Abstract
We have previously demonstrated that in the years following its publication, the ARRIVE trial findings influenced the management of low risk nulliparas. Here we sought to determine if obstetrical providers moved beyond the groups studied in ARRIVE (i.e. low risk nulliparous women) and implemented more frequent induction at 39 weeks among low risk multiparous women as well.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
